Related Pages for COLPAL
- Option Chain
- Straddle OC
- Max Pain
- Put Call Ratio
- Option Analytics
- Call OI vs Put OI
- Strike Flow
- Call OI Chg vs Put OI Chg
- Call Vol vs Put Vol
- Buildup & Unwinding
- Vega Divergence
- Multi Strike OI
- Multi Straddle Analysis
- Price vs OI
- Time Series Table
- Time Series Multi Chart
- Volatility Skew
- Premium Decay
- IV - HV
- IV Intraday
- Future Chain
- Future Intraday Analysis
- Technical
- Financials
- Chart
- About
No results found.
COLPAL
Related News - COLPAL
Colgate-Palmolive: HSBC on Colgate-Palmolive India Maintains Hold with Target Price of ₹2,140 as Q1 sales and volume beat expectations, driven by premiumization and higher ad spending, though growth outlook remains unchanged.
30 Jul 2026 08:59 AM
Colgate-Palmolive: HSBC on Colgate-Palmolive India Maintains Hold with Target Price of ₹2,140 as Q1 sales and volume beat expectations, driven by premiumization and higher ad spending, though growth outlook remains unchanged.
Colgate-Palmolive: Nomura on Colgate-Palmolive India Maintains Buy with Target Price of ₹2,550 as Q1 volume and sales beat estimates, signaling a strong recovery despite margin pressure from higher advertising spends.
30 Jul 2026 08:59 AM
Colgate-Palmolive: Nomura on Colgate-Palmolive India Maintains Buy with Target Price of ₹2,550 as Q1 volume and sales beat estimates, signaling a strong recovery despite margin pressure from higher advertising spends.
Colgate-Palmolive: Jefferies on Colgate-Palmolive India Maintains Buy with Target Price of ₹2,650 as strong topline growth, premiumization, innovation, and improving growth momentum outweigh temporary margin pressure.
30 Jul 2026 09:00 AM
Colgate-Palmolive: Jefferies on Colgate-Palmolive India Maintains Buy with Target Price of ₹2,650 as strong topline growth, premiumization, innovation, and improving growth momentum outweigh temporary margin pressure.
Colgate-Palmolive: Company's Toothpaste Line Sees Strong Volume Growth in High-Single Digits
29 Jul 2026 11:47 AM
Colgate-Palmolive: Company's Toothpaste Line Sees Strong Volume Growth in High-Single Digits
COLGATE PALMOLIVE: Q1 SL NET PROFIT 3.43B RUPEES VS 3.2B (YOY); EST 3.45B
29 Jul 2026 11:44 AM
COLGATE PALMOLIVE: Q1 SL NET PROFIT 3.43B RUPEES VS 3.2B (YOY); EST 3.45B
COLGATE PALMOLIVE: Q1 EBITDA 4.83B RUPEES VS 4.53B (YOY); EST 4.82B || Q1 EBITDA MARGIN 30.4% VS 31.86% (YOY); EST 30.6%
29 Jul 2026 11:46 AM
COLGATE PALMOLIVE: Q1 EBITDA 4.83B RUPEES VS 4.53B (YOY); EST 4.82B || Q1 EBITDA MARGIN 30.4% VS 31.86% (YOY); EST 30.6%
KSOLVES INDIA: Q1 REVENUE 401M RUPEES VS 377M (YOY)
15 Jul 2026 11:45 AM
KSOLVES INDIA: Q1 REVENUE 401M RUPEES VS 377M (YOY)
Colpal: Co To Consider Q1 Results On July 29
15 Jul 2026 11:45 AM
Colpal: Co To Consider Q1 Results On July 29
Colgate-Palmolive (India): Citi on Colgate-Palmolive (India) Sell, Target Price ₹1,900 (cut from ₹2,050), citing balanced revenue growth, pricing gains offset by intense competition, and a lower valuation multiple due to weaker-than-expected medium-term earnings growth.
02 Jul 2026 08:56 AM
Colgate-Palmolive (India): Citi on Colgate-Palmolive (India) Sell, Target Price ₹1,900 (cut from ₹2,050), citing balanced revenue growth, pricing gains offset by intense competition, and a lower valuation multiple due to weaker-than-expected medium-term earnings growth.
Colgate-Palmolive: Citi maintains Sell on Colgate-Palmolive (India) with a Target Price of ₹2,050, citing a more balanced growth trajectory aided by a favorable base, return of pricing but constrained realizations due to competition, premiumization as the key growth driver, and continued margin trade-offs despite healthy gross margins.
17 Jun 2026 09:04 AM
Colgate-Palmolive: Citi maintains Sell on Colgate-Palmolive (India) with a Target Price of ₹2,050, citing a more balanced growth trajectory aided by a favorable base, return of pricing but constrained realizations due to competition, premiumization as the key growth driver, and continued margin trade-offs despite healthy gross margins.
Colgate-Palmolive: JPMorgan maintains a Neutral on Colgate-Palmolive (India) with a Target Price of ₹2,250, citing a positive FY27 outlook driven by balanced volume-price growth, premiumisation in oral care (Total, Whitening, PerioGard), manageable price hikes, improving urban demand, stable rural demand, resilient category trends, and stable-to-improving margins despite higher brand investments.
10 Jun 2026 08:53 AM
Colgate-Palmolive: JPMorgan maintains a Neutral on Colgate-Palmolive (India) with a Target Price of ₹2,250, citing a positive FY27 outlook driven by balanced volume-price growth, premiumisation in oral care (Total, Whitening, PerioGard), manageable price hikes, improving urban demand, stable rural demand, resilient category trends, and stable-to-improving margins despite higher brand investments.
Colgate: HSBC maintains a Hold on Colgate with a Target Price of ₹2150, citing Q4 sales growth ahead of estimates driven equally by volume and value, positive traction in premium products and premiumization as a long-term growth driver, while seeing limited change in overall growth trajectory despite a slight EBITDA estimate upgrade.
25 May 2026 08:59 AM
Colgate: HSBC maintains a Hold on Colgate with a Target Price of ₹2150, citing Q4 sales growth ahead of estimates driven equally by volume and value, positive traction in premium products and premiumization as a long-term growth driver, while seeing limited change in overall growth trajectory despite a slight EBITDA estimate upgrade.
Colgate: Nomura upgrades Colgate to Buy with a Target Price of ₹2500, citing normalization in core portfolio performance, strong premiumization trends, revival in volume growth to 4.5% in Q4, and expectations of near double-digit revenue growth in FY27 driven by mid-single-digit volume and pricing growth without demand backlash.
25 May 2026 09:00 AM
Colgate: Nomura upgrades Colgate to Buy with a Target Price of ₹2500, citing normalization in core portfolio performance, strong premiumization trends, revival in volume growth to 4.5% in Q4, and expectations of near double-digit revenue growth in FY27 driven by mid-single-digit volume and pricing growth without demand backlash.
Colgate: Jefferies maintains a Buy on Colgate with a Target Price of ₹2600, citing resilient core oral care demand, expectations of double-digit EPS growth in FY27 aided by a favorable base after three weak years, and potential for renewed investor interest despite inconsistent revenue growth trends.
25 May 2026 09:00 AM
Colgate: Jefferies maintains a Buy on Colgate with a Target Price of ₹2600, citing resilient core oral care demand, expectations of double-digit EPS growth in FY27 aided by a favorable base after three weak years, and potential for renewed investor interest despite inconsistent revenue growth trends.
Colgate: Citi maintains a Sell on Colgate with a Target Price of ₹2050, citing gradual recovery in growth driven by premiumisation, improving urban demand and favorable base, but expects only steady volume recovery amid rising margin pressure from higher ad spends, GST headwinds and intense competition.
25 May 2026 09:00 AM
Colgate: Citi maintains a Sell on Colgate with a Target Price of ₹2050, citing gradual recovery in growth driven by premiumisation, improving urban demand and favorable base, but expects only steady volume recovery amid rising margin pressure from higher ad spends, GST headwinds and intense competition.
Colgate: Kotak Institutional Equities maintains a Reduce on Colgate with a Target Price of ₹2025, citing strong 9% revenue growth driven by balanced volume and pricing gains, but warning of near-term EBITDA margin pressure from gross margin decline, higher ad spends and the inverted duty structure impact.
25 May 2026 09:00 AM
Colgate: Kotak Institutional Equities maintains a Reduce on Colgate with a Target Price of ₹2025, citing strong 9% revenue growth driven by balanced volume and pricing gains, but warning of near-term EBITDA margin pressure from gross margin decline, higher ad spends and the inverted duty structure impact.
COLGATE PALMOLIVE (INDIA): Q4 SL NET PROFIT 3.53B RUPEES VS 3.6B (YOY) || Q4 REVENUE 15.8B RUPEES VS 14.5B (YOY)
22 May 2026 04:54 PM
COLGATE PALMOLIVE (INDIA): Q4 SL NET PROFIT 3.53B RUPEES VS 3.6B (YOY) || Q4 REVENUE 15.8B RUPEES VS 14.5B (YOY)
COLGATE PALMOLIVE (INDIA): Q4 EBITDA 4.93B RUPEES VS 4.98B (YOY) || Q4 EBITDA MARGIN 31.15% VS 34.3% (YOY)
22 May 2026 04:54 PM
COLGATE PALMOLIVE (INDIA): Q4 EBITDA 4.93B RUPEES VS 4.98B (YOY) || Q4 EBITDA MARGIN 31.15% VS 34.3% (YOY)
COLGATE PALMOLIVE (INDIA): FINAL DIVIDEND OF 24 RUPEES PER SHARE
22 May 2026 04:54 PM
COLGATE PALMOLIVE (INDIA): FINAL DIVIDEND OF 24 RUPEES PER SHARE
